Marco Cicardi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 151 publications

Therapeutic monoclonal antibodies with a focus on hereditary angioedema.

Therapeutic monoclonal antibodies with a focus on hereditary angioedema.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: December 02, 2021

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.

Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.

Journal: Orphanet journal of rare diseases

Published: July 29, 2021

Anti-C1-Inhibitor Autoantibody Detection by ELISA.

Anti-C1-Inhibitor Autoantibody Detection by ELISA.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 13, 2021

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters.

Journal: Thrombosis and haemostasis

Published: November 17, 2020

Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene.

Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene.

Journal: Clinical and molecular allergy : CMA

Published: July 27, 2020

Correction to: The International/Canadian Hereditary Angioedema Guideline.

Correction to: The International/Canadian Hereditary Angioedema Guideline.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: May 14, 2020

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.

Journal: Clinical and experimental immunology

Published: March 28, 2020

Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass.

Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass.

Journal: Anesthesia and analgesia

Published: February 27, 2020

Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.

Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.

Journal: Orphanet journal of rare diseases

Published: February 05, 2020

Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema.

Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema.

Journal: Pediatric allergy, immunology, and pulmonology

Published: January 14, 2020

Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.

Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: December 16, 2019

Lanadelumab for the prevention of attacks in hereditary angioedema.

Lanadelumab for the prevention of attacks in hereditary angioedema.

Journal: Expert review of clinical immunology

Published: November 14, 2019

Showing 1-12 of 151

Last Updated: 09/26/2026